Mucosal barrier enhancement

"Mucosal barrier enhancement" refers to any intervention or therapeutic strategy that strengthens the protective physical and functional layers lining mucosal surfaces, particularly in the GI tract. This involves increasing the production or stability of mucins (such as MUC2), reinforcing tight junctions between epithelial cells, stimulating epithelial repair, and modulating local immune responses via cytokines like IL-22, IL-10, and others. These strategies can be beneficial in conditions where the mucosal barrier is compromised, such as inflammatory bowel disease, infections, and some cancers. Agents that promote mucosal barrier enhancement work by restoring mucus and epithelial integrity, reducing permeability to microbes and antigens, and supporting tissue healing. However, "mucosal barrier enhancement" itself is not a molecular entity, target, or receptor; rather, it is a process or therapeutic goal involving multiple molecular players and pathways.

Other names

Mucosal barrier strengtheningEnhancement of mucosal barrierMucosal barrier function improvement

Physical coating or restoration of the mucus layer; induction of mucin secretion (especially MUC2); modulation of tight junction protein expression; promotion of epithelial repair and proliferation; modulation of immune signaling (e.g., IL-22, IL-10, TNF-α).